
1. plos one. 2014 dec 3;9(12):e113918. doi: 10.1371/journal.pone.0113918.
ecollection 2014.

a chemical proteomics approach search pharmacological targets the
antimalarial clinical candidate albitiazolium plasmodium falciparum using
photocrosslinking click chemistry.

penarete-vargas dm(1), boisson a(1), urbach s(2), chantelauze h(3), peyrottes
s(3), fraisse l(4), vial hj(1).

author information: 
(1)dynamique des interactions membranaires normales et pathologiques, cnrs umr
5235, université montpellier ii, cc107, place eugène bataillon, 34095 montpellier
cedex 05, france.
(2)institut de génomique fonctionnelle, cnrs umr 5203, inserm u661, université
montpellier i, université montpellier ii, f-34094 montpellier, france.
(3)institut des biomolécules max mousseron, cnrs umr 5247, université montpellier
ii, cc1705, place eugène bataillon, 34095 montpellier cedex 05, france.
(4)sanofi, therapeutic strategic unit infectious diseases, 195 route
d'espagne, bp 13669, 31036 toulouse cedex, france.

plasmodium falciparum responsible severe malaria one 
prevalent deadly infectious diseases world. antimalarial
therapeutic arsenal hampered onset resistance known
pharmacological classes compounds, new drugs novel mechanisms of
action critically needed. albitiazolium clinical antimalarial candidate 
from series choline analogs designed inhibit plasmodial phospholipid
metabolism. developed original chemical proteomic approach identify
parasite proteins targeted albitiazolium native interaction in
living parasites. designed bifunctional albitiazolium-derived compound
(photoactivable clickable) covalently crosslink drug-interacting parasite 
proteins situ followed isolation via click chemistry reactions. mass 
spectrometry analysis drug-interacting proteins subsequent clustering on
gene ontology terms revealed parasite proteins involved lipid metabolic
activities and, interestingly, also lipid binding, transport, vesicular
transport functions. accordance this, albitiazolium-derivative was
localized endoplasmic reticulum trans-golgi network p. falciparum. 
importantly, competitive assays albitiazolium, binding of
choline/ethanolamine phosphotransferase (the enzyme involved last step 
phosphatidylcholine synthesis) substantially displaced, thus confirming the
efficiency strategy searching albitiazolium targets.

doi: 10.1371/journal.pone.0113918 
pmcid: pmc4254740
pmid: 25470252  [indexed medline]

